Scientific Publications

Search by Keyword(s)
Found 3 results

Filters: Author is Beauchamp, EM  [Clear All Filters]

Search Results

  • Showing 1-3 of 3 Results
2015
Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer.Terai, H., Tan L., Beauchamp EM, Hatcher JM, Liu Q., Meyerson M., Gray NS, and Hammerman PS ACS chemical biology, 2015/09/25, (2015) Read More / View Supplemental Materials
Abstract
2013
Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors.Akbay, EA, Koyama S., Carretero J., Altabef A., Tchaicha JH, Christensen CL, Mikse OR, Cherniack AD, Beauchamp EM, Pugh TJ, Wilkerson MD, Fecci PE, Butaney M., Reibel JB, Soucheray M., Cohoon TJ, Janne PA, Meyerson M., Hayes DN, Shapiro GI, et al. Cancer discovery, 2013/09/27, (2013) Read More / View Supplemental Materials
Abstract
Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma.Liao, RG, Jung J., Tchaicha JH, Wilkerson MD, Sivachenko A., Beauchamp EM, Pugh TJ, Pedamallu CS, Hayes DN, Gray NS, Getz G., Wong KK, Meyerson M., and Hammerman PS Cancer research, 2013/06/20, (2013) Read More / View Supplemental Materials
Abstract
  • Showing 1-3 of 3 Results